510(k) Report

FDA product code · Immunology

Alpha-1-Lipoprotein, Antigen, Antiserum, Control

DERClass II21 CFR 866.5580510(k) required17 decisions since 19811 recall

17 FDA decisions since 1981. 1 recall names this code; it is not Class I. The most-cited predicate is K993345, named by 1 later device.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, immunology panel

Twenty years of DER at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · DER

FDA has decided no DER device since 2007.

Median 510(k) review, days · DER

Too few DER 510(k)s in any year since 2007 to give a median.

Recalls per year · DER

No recall names DER since 2007.

Adverse event reports per year · DER

2in 2024

2023: 12024: 2
2007high 2 (2024) · low 0 (2007)2025

MAUDE reports naming product code DER, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—01
20240—02
20250—00
20260—0—
FIG. 1 — DER by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in DER? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report